Hyaluronic Acid Raw Material Market To Reach $10.8 Billion By 2030

Hyaluronic Acid Raw Material Market Growth & Trends

The global hyaluronic acid raw material market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2023 to 2030. The increasing use of hyaluronic acid in various medical applications, such as osteoarthritis, wound healing, postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture healing, and soft tissue repair is expected to fuel the market growth over the forecast period. 

The orthopedics segment dominated the overall market in 2015 with the highest revenue generation. The increasing geriatric population base, rising incidence of osteoarthritis, and growing adoption of viscosupplements in the treatments contribute to the large market share of this segment. Furthermore, the drug delivery segment is projected to be the fastest growing over the forecast period with a significantly higher CAGR. The increasing R&D activities focusing on targeted drug delivery systems and growing usage of hyaluronic acid in anti-cancer drug delivery is expected to contribute to the market growth.

The increasing women population of age 35 to 65 years across the globe engenders a greater demand for anti-aging cosmetic and aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels offered by hyaluronic acid-based products, the demand for this polymer in dermal fillers as well as in the treatment of vesicoureteral reflux is expected to experience growth. Thus, it is anticipated that the need for such products will serve as a high impact driver for the hyaluronic acid products over the forecast period. Based on the statistics of the International Society of Aesthetic Plastic Surgery in 2014, there were approximately 20 million cosmetic procedures performed globally, of which nearly 13.5% of the procedures were HA-based non-surgical procedures.

Some of the top countries recording a majority of the aesthetic treatments in 2014 were the U.S., Brazil, Japan, South Korea, Mexico, Germany, France, and Colombia. Medical tourism for cosmetic surgery in the U.S. plays a very important role in aiding the uptake of HA-based products and procedures, which is expected to drive the market in the coming few years.

 Request a free sample copy or view report summary: Hyaluronic Acid Raw Material Market Report

Hyaluronic Acid Raw Material Market Report Highlights

• The orthopedics segment dominated the market in 2022 with the largest revenue share of 39.7% owing to the growing adoption of technologically advanced drugs coupled with the wide usage of hyaluronic acid in the treatment procedures of osteoarthritis.

• The introduction of FDA-approved hyaluronic acid-based viscosupplements such as ORTHOVISC and MONOVISC is expected to boost usage over the next 8 years

• Some of the key market players are Salix Pharmaceuticals; ALLERGAN; Lifecore Biomedical, LLC; Anika Therapeutics, Inc.; Smith & Nephew; Maruha Nichiro Corporation; Ferring B.V.; SEIKAGAKU CORPORATION; F. Hoffmann-La Roche Ltd., Zimmer Biomet; and others

Hyaluronic Acid Raw Material Market Segmentation

Grand View Research has segmented the global hyaluronic acid raw material market is segmented based on its application, source, grade, and region:

Hyaluronic Acid Raw Material Application Outlook (Revenue, USD Million, 2018 - 2030)

• Ophthalmology

• Cataract surgery

• Aqueous eye drop

• Contact lens

• Orthopedics

• Viscosupplements

• Bone regeneration

• Dermatology

• Intradermal

• Dermal filler

• Wound healing

• Drug Delivery

• Medical Device Coating

• Surgical Adhesion Prevention

• Biomaterials and Implants

• Cell and Tissue Preservation

Hyaluronic Acid Raw Material Source Outlook (Revenue, USD Million, 2018 - 2030)

• Non-Animal

• Animal

Hyaluronic Acid Raw Material Grade Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical

• Cosmetic

• Orthopedic

Hyaluronic Acid Raw Material Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• France

• Italy

• Spain

• Denmark

• Sweden

• Norway

• Asia Pacific

• Japan

• China

• India

• Australia

• Thailand

• South Korea

• Latin America

• Brazil

• Mexico

• Argentina

• Middle East & Africa

• South Africa

• Saudi Arabia

• UAE

• Kuwait

List of Key Players of Hyaluronic Acid Raw Material Market

• AbbVie Inc.

• Salix Pharmaceuticals

• Lifecore Biomedical, Inc.

• Sanofi

• Anika Therapeutics, Inc.

• Zimmer Biomet

• Smith+Nephew

• LG Chem

• Maruha Nichiro Corporation

• Ferring B.V.

• SEIKAGAKU CORPORATION

• F. Hoffmann-La Roche Ltd.